Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.
about
Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivityCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusMinimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig ModelA Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig modelSmall molecules with antiviral activity against the Ebola virusMachine learning models identify molecules active against the Ebola virus in vitroDevelopment of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system.Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS.FDA approved drugs as potential Ebola treatments.Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40.Antiviral Screening of Multiple Compounds against Ebola VirusTargeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesRepurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review.Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds.MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola VirusPan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors
P2860
Q28066142-966E3F53-FAA7-4982-9B22-DCE811FFD465Q28084005-F963E974-580B-442A-83D8-7CBCF01B876CQ28553683-93548CC9-B6C3-4E1D-8BF6-720BD96B8C82Q33441225-818A8244-DA4C-4FA3-9A00-0501DE13F90AQ33617999-FA9FE24F-5608-414E-886F-4D6FA243B7F3Q34464403-CE971B99-B21B-4697-B596-EAA73295E7E4Q35911643-C5D1FFD5-F3C3-4E8A-AF42-A7B946995520Q37652192-08BB0835-F300-4D08-BCD0-31688DBC9D7CQ38530430-D01A9C2B-45A0-499F-A51B-84A437CC94E4Q39027505-3FA41262-84B6-4FBD-B04E-11E399F220FEQ39216411-FA63D559-9BDF-4C02-9299-FD35C2634FE5Q39227786-C26C8A5F-034B-4F49-B187-B560B2FC1BA7Q39360987-F11D7786-48F9-4A38-9315-B7A4F276489CQ40045378-258B2325-0F01-4487-9E58-888C2848EA73Q40054455-1B17671A-6D8D-42ED-A99C-BF6A48FD3DC5Q54250885-39D84CEF-FFA6-40E9-8774-38B67FE89621Q56535662-6EB775DA-8480-488E-BFA3-7EC4095D00CEQ57092281-DF3ADD74-BAFE-432A-A64B-EDB47B7B131D
P2860
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Antiviral therapies against Eb ...... icines that block virus entry.
@ast
Antiviral therapies against Eb ...... icines that block virus entry.
@en
type
label
Antiviral therapies against Eb ...... icines that block virus entry.
@ast
Antiviral therapies against Eb ...... icines that block virus entry.
@en
prefLabel
Antiviral therapies against Eb ...... icines that block virus entry.
@ast
Antiviral therapies against Eb ...... icines that block virus entry.
@en
P2860
P50
P1433
P1476
Antiviral therapies against Eb ...... icines that block virus entry.
@en
P2093
Eleonora Molesti
P2860
P356
10.12688/F1000RESEARCH.6085.2
P577
2015-01-29T00:00:00Z